Anti-Aging Clinics Appeal to Menopausal Women
the Endocrinology Advisor take:
Women have been seeking treatment for their menopausal symptoms from ‘anti-aging’ clinicians, according to a study evaluating the appeal of anti-aging medicine.
Some women believed that conventional doctors did not take their symptoms seriously, the findings suggested, while some also were afraid of side effects of conventional hormone replacement therapy.
However, they considered the bioidentical hormones, or “natural” hormones, prescribed by the anti-aging clinicians to be safe despite a lack of evidence.
The researchers also conducted in-depth interviews with 25 women who used bioidentical hormone replacement therapy prescribed by anti-aging clinicians. Their goals, they reported, were relieving menopausal symptoms, increasing energy and avoiding chronic illnesses.
Other reasons women visited anti-aging clinicians included the belief that patients received more time and attention from clinicians; medications were viewed as “natural”; and bioidentical hormone replacement therapy was seen as safer than conventional hormone therapy.
Women were often prescribed bioidentical hormone therapy derived from plants such as soy and yams. These hormonal therapies are unregulated by the FDA and produced at compounding pharmacies.
Nurse-managed protocols improved outpatient care in chronic illnesses
Endocrinology Advisor Articles
- FDA Approves Admelog Short-Acting Insulin Lispro Injection
- Fertility Hormone Therapy and Cardiovascular Outcomes: What We Know
- Effects of Peer Influence in Adolescents With Type 1 Diabetes
- More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes
- One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements
- FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels
- Injected and Oral Medications Equally Safe for Gestational Diabetes
- Adjunctive Dapagliflozin Improves Glycemic Control in T1D
- Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women
- Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death
- Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D
- Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes
- Oral Insulin Not a Reliable Preventive Strategy for Type 1 Diabetes
- Prevention of Bone Mineral Density Loss Needed in Epilepsy
- Gastric Bypass Blunts B-Cell Sensitivity During Glycemia